Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.
|Title||Current Drug Targets|
|Abbreviation||Curr. Drug Targets|
|Subject Area, Categories, Scope||Clinical Biochemistry (Q2); Drug Discovery (Q2); Molecular Medicine (Q2); Pharmacology (Q2)|
|SCImago Journal Rank (SJR)||0.826|
|Publisher||Bentham Science Publishers B.V.|
|Country||United Arab Emirates|
Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal is devoted to a single timely topic, with series of in-depth reviews, written by leaders in the field, covering a range of current topics on drug targets. These issues are organized and led by a Guest Editor who is a recognized expert in the overall topic. As the discovery, identification, characterisation and validation of novel human drug targets for drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.
Current Drug Targets is a journal covering the technologies/fields/categories related to Clinical Biochemistry (Q2); Drug Discovery (Q2); Molecular Medicine (Q2); Pharmacology (Q2). It is published by Bentham Science Publishers B.V.. The overall rank of Current Drug Targets is 5785. According to SCImago Journal Rank (SJR), this journal is ranked 0.826. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 102. The best quartile for this journal is Q2.
The ISSN of Current Drug Targets journal is 18735592, 13894501. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Current Drug Targets is cited by a total of 1463 articles during the last 3 years (Preceding 2020).
The impact score (IS) 2020 of Current Drug Targets is 3.03, which is computed in 2021 as per its definition. Current Drug Targets IS is increased by a factor of 0.5 and approximate percentage change is 19.76% when compared to preceding year 2019, which shows a rising trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
IS 2020 of Current Drug Targets is 3.03. If the same upward trend persists, impact score of joule may rise in 2021 as well.
|Year||Impact Score (IS)|
Current Drug Targets has an h-index of 102. It means 102 articles of this journal have more than 102 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Current Drug Targets is 18735592, 13894501. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Current Drug Targets is 5785. According to SCImago Journal Rank (SJR), this journal is ranked 0.826. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
Current Drug Targets is published by Bentham Science Publishers B.V.. It's publishing house is located in United Arab Emirates. Coverage history of this journal is as following: 2000-2020. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Current Drug Targets is Curr. Drug Targets. This abbreviation ('Curr. Drug Targets') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Clinical Biochemistry (Q2); Drug Discovery (Q2); Molecular Medicine (Q2); Pharmacology (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
|Journal/Conference/Workshop/Book Title||Type||Ranking||Publisher||h-index||Impact Score|
|Neurosurgical Review||journal||3992||Springer Verlag||60||2.73|
|Printwear||trade journal||32410||National Business Media, Inc.||1||0.00|
|Journal of Applied Toxicology||journal||6184||John Wiley and Sons Ltd||87||3.28|
|Journal of Empirical Research on Human Research Ethics||journal||7352||SAGE Publications Inc.||29||1.38|
|Society of Petroleum Engineers - SPE/IATMI Asia Pacific Oil and Gas Conference and Exhibition 2017||conference and proceedings||23947||3||0.00|
|Cardiovascular Diagnosis and Therapy||journal||5742||AME Publishing Company||22||2.13|
|Zhongguo Gonglu Xuebao/China Journal of Highway and Transport||journal||10048||Xi'an Highway University||30||1.43|
|Journal of Real-Time Image Processing||journal||14826||Springer Verlag||34||2.30|
|Journal of the American Water Resources Association||journal||4667||Wiley-Blackwell Publishing Ltd||105||2.71|
|Vingtieme Siecle: Revue d'Histoire||journal||27216||Presses de Sciences Po||14||0.07|
|Year||Impact Score (IS)|